Therapeutic EUS is a growing and exciting field that is advancing endoscopic treatments for patients with complex pancreaticobiliary diseases. Learn more about the AXIOS™ Stent and Delivery System below.*
AXIOS System In-Service Videos
Video
Procedural Tips and Techniques for the AXIOS™ Platform, by Todd Baron, MD
Dr. Baron takes an in-depth look at the AXIOS Platform, sharing procedural tips and techniques, different methods and imaging modalities.
AXIOS System Webcast Series
Video
Watch this webcast presented by Martin L. Freeman M.D., FACG, FASGE; Professor of Medicine, Chief, Division of Gastroenterology, at the University of Minnesota.
Video
Evaluating when Intervention is Appropriate for PFC Patients, by Thomas Kowalski, MD
Dr. Kowalski discusses patient selection criteria and the characteristics of pancreatic fluid collections (PFCs) to determine when to provide therapeutic intervention.
Video
AXIOS™ Stent System Placement: Techniques, Best Practices and Watch Out, by Amrita Sethi, MD
Watch this webcast presented by Amrita Sethi MD where she discusses tips and techniques for success in using the AXIOS System
Video
Options after Stent Placement for Walled Off Necrosis (WON), by Todd Baron, MD
Watch this webcast presented by Todd Baron M.D. on his options and techniques for after AXIOS™ Stent placement.
Video
Necrosectomy Techniques, by Shyam Varadarajulu, MD
Hear Dr. Varadarajulu’s opinions on necrosectomy techniques and other considerations for AXIOSTM Stent post-placement.
Video
Janak Shah, MD and Charles Conway, MD discuss the multidisciplinary management of inflammatory pancreatic fluid collections.
Physician Perspectives
Video
Managing Pancreatic Collections and WON: The Changing Landscape
Four physician experts share their expertise and best practices managing these patients.
*The AXIOS™ Stent and Electrocautery-Enhanced Delivery System Indications for Use:
• US: The AXIOS Stent and Electrocautery-Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts 6cm in size, with >70% fluid content that are adherent to the gastric or bowel wall. Once place, the AXIOS Stent functions as an access port allowing passage of standard and therapeutic endoscopes to facilitate debridement, irrigation and cystoscopy. The stent is intended for implantation up to 60 days and should be removed upon confirmation of pseudocyst resolution.
• Europe: The Hot AXIOS Stent and Electrocautery Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst, walled-off necrosis (>70% fluid content) or the biliary tract.
CAUTION: U.S. Federal law restricts device to sale by or on the order of a physician.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for the use only in countries with applicable health authority registrations. Material not intended for use in France.
All trademarks are the property of their respective owners.
For health care professionals in Europe:
Please note that the pages on this website are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
BROADCASTMED